• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NZX
Click for more information
0.89% $1.11

NZX Limited Ordinary Shares - News & Media

watchlist Created with Sketch. Add to my watchlist
Financial Services

No News & Media currently available.

(20min delay)
Last
$1.11 		Change
-0.010(0.89%) 		Mkt cap ! n/a
Open High Low Value Volume
$1.13 $1.14 $1.10 $43.76K 39.17K

Buyers (Bids)

No. Vol. Price($)
0 29120 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.14 3942 0
Last trade - 12.59pm 15/05/2024 (20 minute delay) ?
NZX (NZSX) Chart

Top Stories

Want copper with that? Boss Energy hits orange metal on-site uranium play

The exploration team at Boss Energy announced on Wednesday that its latest drill run on-site has successfully found copper.
Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing Sun Silver is enjoying a strong debut on the local bourse with shares up 100% to 40cps as miners enjoy budgetary stimulus.
Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management Industry specialist Shekel Brainweigh (ASX:SBW) has built AI into its high-tech product scale and weighing technologies.
Market Close: Materials win on critical minerals, hydrogen budget promises Renascor Resources (ASX:RNU) was the biggest winner gaining 30 per cent without market news, while Chalice Mining (ASX:CHN), Vulcan Energy Resources (ASX:VUL) and Aeris Resources (ASX:AIS) all gained between 7 and 10 per cent.
Recce Pharma heading closer to full efficacy data for flagship R327 Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial has been dosed.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.